| Literature DB >> 24379601 |
Daniel Oliveira Beraldo1, Joanderson Fernandes Melo1, Alexandre Vidal Bonfim1, Andrei Alkmim Teixeira1, Ricardo Alkmim Teixeira1, André Loyola Duarte1.
Abstract
Amoxicillin/clavulanate is a synthetic penicillin that is currently commonly used, especially for the treatment of respiratory and cutaneous infections. In general, it is a well-tolerated oral antibiotic. However, amoxicillin/clavulanate can cause adverse effects, mainly cutaneous, gastrointestinal, hepatic and hematologic, in some cases. Presented here is a case report of a 63-year-old male patient who developed cholestatic hepatitis after recent use of amoxicillin/clavulanate. After 6 wk of prolonged use of the drug, he began to show signs of cholestatic icterus and developed severe hyperbilirubinemia (total bilirubin > 300 mg/L). Diagnostic investigation was conducted by ultrasonography of the upper abdomen, serum tests for infection history, laboratory screening of autoimmune diseases, nuclear magnetic resonance (NMR) of the abdomen with bile duct-NMR and transcutaneous liver biopsy guided by ultrasound. The duration of disease was approximately 4 mo, with complete resolution of symptoms and laboratory changes at the end of that time period. Specific treatment was not instituted, only a combination of anti-emetic (metoclopramide) and cholestyramine for pruritus.Entities:
Keywords: Amoxicillin/Clavulanate; Drug reactions; Hepatitis; Hepatology; Hyperbilirubinemia
Mesh:
Substances:
Year: 2013 PMID: 24379601 PMCID: PMC3870529 DOI: 10.3748/wjg.v19.i46.8789
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742